
zzso in breast cancer is associated with tamoxifen resistance, but little data exist on its interaction with zzso deprivation or zzso Here, we used an in zzso zzso model of zzso zzso zzso breast cancer with zzso zzso zzso to investigate mechanisms of growth zzso and treatment zzso zzso tumors were growth inhibited by zzso deprivation and with zzso but resistance developed in 2 to 3 zzso zzso tumors had reductions in zzso zzso growth zzso zzso zzso zzso zzso zzso and zzso zzso zzso protein zzso zzso zzso was increased especially in tumors sensitive to zzso zzso zzso with acquired resistance to these therapies had complete loss of zzso increased zzso increased zzso and reduced zzso In contrast, zzso and zzso zzso zzso levels were markedly reduced in these resistant zzso The zzso growth factor zzso zzso zzso zzso inhibitor zzso which can block zzso zzso significantly delayed the emergence of resistance to both zzso deprivation and zzso zzso of zzso and zzso decreased with zzso whereas high zzso levels were zzso Eventually, however, tumors progressed in mice treated with zzso combined with zzso deprivation or zzso accompanied again by loss of zzso and zzso increased zzso high zzso and now increased zzso Thus, zzso deprivation and zzso can effectively inhibit zzso tumors but resistance develops zzso zzso zzso can delay resistance, but zzso of zzso and signaling through zzso leads to tumor zzso Combining zzso therapy with zzso zzso should be tested in clinical breast cancer, but a more complete blockade of zzso may be zzso 

